Investigational Site Number : 3920010

Tachikawa-shi, Tokyo 190-0023

0 studies enrolling now · 1 studies all time

What they study most

Chronic Spontaneous Urticaria

Studies at this site

• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) — Completed